language_icon
EN
HI

Apollo Hospitals Enterprise Share price

APOLLOHOSP

8308.5

230.00 (2.85%)
NSE
BSE
Last updated on 21 May, 2026 | 15:56 IST
Today's High

8388.00

Today's Low

8051.50

52 Week Low

6696.50

52 Week High

8388.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Apollo Hospitals Enterprise Chart

Apollo Hospitals Enterprise Share Key Metrics

Volume
14.25 L
Market Cap
119463.48 CR
LTQ@LTP
12@8308.50
ATP
8253.85
Var Margin
12.5 %
Circuit Range
7271-8886
Delivery %
51.19 %
Value
1176.28 CR
ASM/GSM
No
Market Lot
1

Summary

Apollo Hospitals Enterprise share price is ₹8308.5 as of 22 May, 2026. The stock Apollo Hospitals Enterprise intraday movement has stayed between ₹8051.50 and ₹8388.00, while on a 52-week basis,Apollo Hospitals Enterprise price 52 week high is ₹8388.00 & its 52 week low is ₹6696.50.
In terms of trading activity, Apollo Hospitals Enterprise has recorded a volume of 1425124 shares, The Apollo Hospitals Enterprise has a market cap of ₹143784657 CR. The stock’s Average Traded Price (ATP) stands at ₹8253.85, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 12 @ ₹8308.50.
Apollo Hospitals Enterprise operates within a circuit range of ₹7271.00 – ₹8886.00, with a Value of ₹1176.28 CR. The Delivery Percentage for the day is 51.19%. Additionally, Apollo Hospitals Enterprise currently falls under the No framework, and trades with a market lot size of 1.

Apollo Hospitals Enterprise Fundamentals

View More
P/E Ratio

59.97

P/B Ratio

12.15

Div. Yield

0.23

Sector P/E

56.75

Sector P/B

-15.78

Sec. Div. Yield

0.19

Apollo Hospitals Enterprise Resistance and Support

Pivot 8011

Resistance

First Resistance

8207.5

Second Resistance

8336.5

Third Resistance

8533

Support

First Support

7882

Second Support

7685.5

Third Support

7556.5

Apollo Hospitals Enterprise Futures & Options

link_white_icon

Apollo Hospitals Enterprise Option Chain

View Price, OI, Greeks & More...
View All

26MAY26

8332.00

241.50 (2.98%)

30JUN26

8380.50

240.50 (2.95%)

28JUL26

8416.50

226.50 (2.77%)

APOLLOHOSP|26MAY26 CE 8300.00

120.00

4.8 (4.17%)

APOLLOHOSP|26MAY26 PE 8350.00

108.85

-785.75 (-87.83%)

Apollo Hospitals Enterprise Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

28.02%

Mutual Fund

16.65%

Insurance

4.66%

Foreign Institutional Investors

42.62%

Domestic Institutional Investors

1.68%

Retail

6.37%

Others

0%

Total Promoters
MAR '26
28.02%

Apollo Hospitals Enterprise Corporate Actions

DateAgenda
2026-05-20Audited Results & Final Dividend
2026-02-10Quarterly Results
2025-11-06Quarterly Results
2025-08-12Quarterly Results & Others
2025-05-30Audited Results
2025-02-10Quarterly Results & Interim Dividend

Apollo Hospitals Enterprise News

Q4 Results LIVE Updates: Aurobindo Pharma profit flat, revenue 6%; Datamatics margin expands

Apollo Hospitals reported a significant increase in its Q4 FY26 financial results, with consolidated net profit rising 35.9% year-on-year to ₹529.3 crore and revenue from operations growing 18.1% year-on-year to ₹6,605.5 crore.
May 21 2026 19:05:00

Q4 Results LIVE Updates: GAIL profit falls 21%, margin shrinks; Honasa Consumer profit doubles

Apollo Hospitals Enterprise reported robust Q4 FY26 consolidated revenue of ₹5,000 crore, a 15% year-on-year increase, with net profit rising 20% to ₹450 crore. The board also recommended a final dividend of ₹10 per share for FY26.
May 21 2026 19:05:00

Q4 Results LIVE Updates: Honasa Consumer profit more than doubles; Welspun Corp profit falls 47%

Apollo Hospitals reported a significant increase in its consolidated net profit for Q4 FY26, rising by 35.9% year-on-year to ₹529.3 crore. The company's revenue from operations also saw an 18.1% year-on-year growth, reaching ₹6,605.5 crore. Additionally, the board has recommended a dividend of ₹10 per share.
May 21 2026 18:05:00

Q4 Results LIVE Updates: Welspun Corp profit falls 47%; Juniper Hotels margin improves

Apollo Hospitals Enterprise Limited announced its Q4 FY26 results, reporting revenue of ₹4,800 crore, marking a 15% year-on-year increase, and a net profit of ₹250 crore, up 20% year-on-year.
May 21 2026 18:05:00

Apollo Hospitals Enterprise Ltd - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Apollo Hospitals has released the audio recording of its analyst call, where the financial results for the three months and year ended March 31, 2026, were discussed. This recording is now available on the company's website for investor access.
May 21 2026 18:05:00

Q4 Results LIVE Updates: VA Tech Wabag profit up 29%; Sun TV profit falls 37%

Analysts anticipate Apollo Hospitals will report a 9% year-on-year growth in hospital EBITDA for Q4 FY26, with overall revenues projected to increase by 19% year-on-year. HealthCo sales are expected to grow 21% year-on-year, though the hospital EBITDA margin is forecast to decline by 130 basis points quarter-on-quarter to 23.5%.
May 21 2026 17:05:00

Q4 Results LIVE Updates: Sun TV profit falls 37%; Max Health revenue rises 12%

Apollo Hospitals Enterprise Ltd. reported a strong financial performance for Q4 FY26, with consolidated net profit surging 36% year-on-year to ₹529 crore and revenue increasing 18% to ₹6,606 crore. The company also declared a final dividend of ₹10 per share.
May 21 2026 16:05:00

Q4 Results LIVE Updates: Max Health revenue rises 12%; Nykaa margin expands

Apollo Hospitals reported strong Q4 FY26 consolidated results, with net profit jumping 35.9% year-on-year to ₹529.3 crore and revenue from operations increasing 18.1% to ₹6,605.5 crore. The board also recommended a final dividend of ₹10 per share for the financial year.
May 21 2026 16:05:00

Apollo Hospitals, Honeywell Automation rally; Sensex falls 135 points, Nifty flat

Apollo Hospitals stock rallied today, contrasting with the broader market trend where the Sensex declined by 135 points and the Nifty remained flat. The article highlights Apollo Hospitals as one of the buzzing stocks amidst general market movements, without citing specific company-related catalysts for its upward move.
May 21 2026 15:05:00

Q4 Results LIVE Updates: Sandhar Technologies profit up 50%; Emami margin shrinks

Apollo Hospitals Enterprise reported a strong financial performance for Q4 FY26, with consolidated net profit surging 36% year-on-year to ₹529 crore and revenue increasing 18% to ₹6,606 crore. The company also declared a final dividend of ₹10 per share, with the record date set for August 14, 2026.
May 21 2026 14:05:00
Read More

About Apollo Hospitals Enterprise

NSE : 157  
BSE : 508869  
ISIN : INE437A01024  

Apollo Hospitals Enterprise Management

NamePosition
Prathap C ReddyChairman
Preetha ReddyVice Chairperson
View More

Apollo Hospitals Enterprise FAQs

The Buying Price of Apollo Hospitals Enterprise share is 8308.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Apollo Hospitals Enterprise stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Apollo Hospitals Enterprise, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Apollo Hospitals Enterprise shares is 59.97. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Apollo Hospitals Enterprise shares is 12.15. Useful to assess the stock's value relative to its book value.

To assess Apollo Hospitals Enterprise’s valuation compare Sector P/E, P/B which are 56.75 & -15.78 with sector averages, along with growth rates and financial metrics.

The Market Cap of Apollo Hospitals Enterprise is 119463.48 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Apollo Hospitals Enterprise share price is 8388.00 & 6696.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Apollo Hospitals Enterprise belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost